The Chemours Company CC
$14.58
-$0.45-2.99%
NYSE
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 1.59B | 1.38B | 1.33B | 1.50B | 1.62B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.59B | 1.38B | 1.33B | 1.50B | 1.62B |
| Cost of Revenue | 1.31B | 1.17B | 1.17B | 1.26B | 1.34B |
| Gross Profit | 286.00M | 212.00M | 159.00M | 235.00M | 278.00M |
| SG&A Expenses | 241.00M | 145.00M | 105.00M | 105.00M | 129.00M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.57B | 1.34B | 1.30B | 1.39B | 1.49B |
| Operating Income | 18.00M | 41.00M | 27.00M | 104.00M | 121.00M |
| Income Before Tax | -1.00M | -22.00M | -67.00M | 51.00M | -248.00M |
| Income Tax Expenses | 273.00M | 7.00M | -5.00M | -9.00M | 131.00M |
| Earnings from Continuing Operations | -274.00M | -29.00M | -62.00M | 60.00M | -379.00M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | 1.00M | -- | -1.00M |
| Net Income | -274.00M | -29.00M | -61.00M | 60.00M | -380.00M |
| EBIT | 18.00M | 41.00M | 27.00M | 104.00M | 121.00M |
| EBITDA | 98.00M | 120.00M | 131.00M | 183.00M | 213.00M |
| EPS Basic | -1.81 | -0.19 | -0.41 | 0.40 | -2.53 |
| Normalized Basic EPS | -0.15 | 0.00 | -0.13 | 0.21 | 0.26 |
| EPS Diluted | -1.81 | -0.19 | -0.41 | 0.40 | -2.53 |
| Normalized Diluted EPS | -0.15 | 0.00 | -0.13 | 0.21 | 0.26 |
| Average Basic Shares Outstanding | 151.23M | 150.77M | 150.47M | 150.32M | 150.24M |
| Average Diluted Shares Outstanding | 151.23M | 150.77M | 150.47M | 150.78M | 150.24M |
| Dividend Per Share | 0.09 | 0.09 | 0.09 | 0.09 | 0.09 |
| Payout Ratio | -4.74% | -44.83% | -24.59% | 21.67% | -3.42% |